α2,6-Sialoglycan-regulated anti-tumor immunity of tumor-infiltrating CD8+ T cells in the tumor microenvironment [CD8+T]
Single-cell RNA-seq · mouse · 27 samples
- What it is
- Single-cell RNA-seqGene activity measured in thousands of individual cells, so cell types can be told apart. Read from the summary: GEO's own type field only says 'expression profiling by sequencing', so confirm it in the paper.
- Organism
- Mus musculus (mouse)
- Samples
- 27 samples: 9 conditions, mostly in triplicateGroups are read from the sample names, not from the paper. Check the list below.
- Data you can get
- A processed table (series matrix) and supplementary files from NCBI; the raw sequencing reads from ENA. Which of these hold counts depends on the study, so check the file list.
Read the full summary ↓
Direct links to NCBI and ENA, no account and no request form. Pick by what you want to do: take the small processed table to look, the supplementary files to re-analyse, or the original raw data to start over.
Processed table
The series matrix: one table of values per sample as the submitters processed it. The smallest download, and it opens in Excel or R. Start here to see what the data look like.
Supplementary files
The count tables and other files the authors uploaded. Take only the samples you need, or the whole study as GSE316541_RAW.tar (it can run to tens of gigabytes).
Raw sequencing reads
The original FASTQ files, straight from the sequencer, held at ENA. Large, and you align them yourself, so only choose this if you need to re-process the study from scratch.
What the files usually look like: Single-cell studies usually ship their counts as 10x files (matrix.mtx, barcodes.tsv, features.tsv), an .h5 file, or an .rds / .h5ad object that Seurat or Scanpy can open. Look for those among the supplementary files.
Also filed as BioProject PRJNA1403296 and SRA study SRP662662. Searching any of these in the dataset finder brings you back here.
Supports a between-group comparison across 27 samples.
How we read this: 9 replicated groups read from 27 sample titles; they account for 27 of them. These groups are guessed from the sample names, not taken from the paper, so check them against the sample list below before relying on them.
- GSM9455555 OT1 CD8+T, day0, rep1 OT1 CD8+T, day0,
- GSM9455556 OT1 CD8+T, day0, rep2 OT1 CD8+T, day0,
- GSM9455557 OT1 CD8+T, day0, rep3 OT1 CD8+T, day0,
- GSM9455558 OVA stimulated, day2, rep1 OVA stimulated, day2,
- GSM9455559 OVA stimulated, day2, rep2 OVA stimulated, day2,
- GSM9455560 OVA stimulated, day2, rep3 OVA stimulated, day2,
- GSM9455561 Q4 stimulated, day2, rep1 Q4 stimulated, day2,
- GSM9455562 Q4 stimulated, day2, rep2 Q4 stimulated, day2,
- GSM9455563 Q4 stimulated, day2, rep3 Q4 stimulated, day2,
- GSM9455564 V4 stimulated, day2, rep1 V4 stimulated, day2,
- GSM9455565 V4 stimulated, day2, rep2 V4 stimulated, day2,
- GSM9455566 V4 stimulated, day2, rep3 V4 stimulated, day2,
- GSM9455567 OVA stimulated, day1, rep1 OVA stimulated, day1,
- GSM9455568 OVA stimulated, day1, rep2 OVA stimulated, day1,
- GSM9455569 OVA stimulated, day1, rep3 OVA stimulated, day1,
- GSM9455570 Q4 stimulated, day1, rep1 Q4 stimulated, day1,
- GSM9455571 Q4 stimulated, day1, rep2 Q4 stimulated, day1,
- GSM9455572 Q4 stimulated, day1, rep3 Q4 stimulated, day1,
- GSM9455573 V4 stimulated, day1, rep1 V4 stimulated, day1,
- GSM9455574 V4 stimulated, day1, rep2 V4 stimulated, day1,
- GSM9455575 V4 stimulated, day1, rep3 V4 stimulated, day1,
- GSM9455576 CD3/CD28 Dynabeads stimulated, day1, rep1 CD3/CD28 Dynabeads stim…
- GSM9455577 CD3/CD28 Dynabeads stimulated, day1, rep2 CD3/CD28 Dynabeads stim…
- GSM9455578 CD3/CD28 Dynabeads stimulated, day1, rep3 CD3/CD28 Dynabeads stim…
- GSM9455579 anti-CD3 antibody stimulated, day1, rep1 anti-CD3 antibody stimu…
- GSM9455580 anti-CD3 antibody stimulated, day1, rep2 anti-CD3 antibody stimu…
- GSM9455581 anti-CD3 antibody stimulated, day1, rep3 anti-CD3 antibody stimu…
- GSE316540 α2,6-Sialoglycan-regulated anti-tumor immunity of tumor-infiltrating CD8+ T cells in the tumor microenvironment 9 samples shares cd8, 6-sialoglycan-regulated, tumor-infiltrating, microenvironment, anti-tumor, immunity
- GSE234974 Pan-cancer mapping of single CD8+ T cell profiles reveals a TCF1:CXCR6 axis regulating CD28 co-stimulation and anti-tumor immunity I 24 samples shares cd8, anti-tumor, immunity
- GSE277610 Endothelial PD-L1 brakes CD8+ T cell exhaustion, empowering anti-tumor immunity in non-small cell lung cancer 17 samples shares cd8, anti-tumor, immunity
- GSE207029 Blockade of avb8 integrin synergizes with checkpoint inhibition to enhance anti-tumor immunity through Cxcl9-dependent augmentation of CD8+ T cell cytotoxicity 12 samples shares cd8, anti-tumor, immunity
- GSE290839 PD-1 regulates tumor-infiltrating CD8+ T cells in both a cell-intrinsic and cell-extrinsic fashion [scRNA-seq] 20 samples shares cd8, tumor-infiltrating
- GSE299133 Host MTDH orchestrates liver lipid metabolism and CD8+ T cells to suppress antitumor immunity [Hepatocytes] 18 samples shares cd8, immunity
- GSE276107 Host MTDH orchestrates liver lipid metabolism and CD8+ T cells to suppress antitumor immunity 44 samples shares cd8, immunity
- GSE270050 Expansion of Tumor-Infiltrating CD8+ T Cell Clonotypes Occurs in the Spleen in Response to Immune Checkpoint Blockade 29 samples shares cd8, tumor-infiltrating
Metadata from NCBI GEO, cached and refreshed periodically — the NCBI page above is authoritative. Downloads link straight to NCBI/ENA; nothing is proxied through BioTransfer.